Category: Atherosclerosis

High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events

Post author By Stoekenbroek R M, Rensing K L, Moens S J B, Nieuwdorp M, De Vries J, Zwinderman A H, Stroes E S, Currie C J and Hutten B A
Post date 30 March 2015

Stoekenbroek R M, Rensing K L, Moens S J B, Nieuwdorp M, DeVries J H, Zwinderman A H, Stroes E S, Currie C J and Hutten B A. 30 Mar 2015

Atherosclerosis

Endogenous hyperinsulinaemia and exogenous insulin: A common theme between atherosclerosis, increased cancer risk and other morbidities

Post author By Holden S E and Currie C J
Post date 1 May 2012

Holden S E, Currie C J. 01 May 2012

Atherosclerosis

Risk of macrovascular complications in diabetes: comparison of the influence of gender on ischaemic heart disease and cerebrovascular disease

Post author By Hanna F W F, Currie C J, Morgan C L, Peters J R and Rees D A
Post date 5 October 1997

Hanna F W F, Currie C J, Morgan C L, Peters J R, Rees A. 05 Oct 1997

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit